These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16171602)

  • 1. Effect of tissue plasminogen activator on vascular smooth muscle cells.
    Yang Z; Eton D; Zheng F; Livingstone AS; Yu H
    J Vasc Surg; 2005 Sep; 42(3):532-8. PubMed ID: 16171602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neointimal hyperplasia on a cell-seeded polytetrafluoroethylene graft is promoted by transfer of tissue plasminogen activator gene and inhibited by transfer of nitric oxide synthase gene.
    Yu H; Dai W; Yang Z; Romaguera RL; Kirkman P; Rowe VL
    J Vasc Surg; 2005 Jan; 41(1):122-9. PubMed ID: 15696054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
    Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroviral vector-mediated transfer and expression of human tissue plasminogen activator gene in human endothelial and vascular smooth muscle cells.
    Ekhterae D; Stanley JC
    J Vasc Surg; 1995 Jun; 21(6):953-62. PubMed ID: 7776475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of neointima formation with tissue-type plasminogen activator.
    Hilfiker PR; Waugh JM; Li-Hawkins JJ; Kuo MD; Yuksel E; Geske RS; Cifra PN; Chawla M; Weinfeld AB; Thomas JW; Shenaq SM; Dake MD
    J Vasc Surg; 2001 Apr; 33(4):821-8. PubMed ID: 11296338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibrinolytic properties of the vascular wall. Dependence on the history of smooth muscle cell doublings in vitro and in vivo.
    Christ G; Hufnagl P; Kaun C; Mundigler G; Laufer G; Huber K; Wojta J; Binder BR
    Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):723-30. PubMed ID: 9108786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects and mechanism of tissue-type plasminogen activator and plasminogen activator inhibitor on vascular smooth muscle cell proliferation.
    Xiaoli M; Wenying H; Mingpeng S
    Int J Cardiol; 1998 Oct; 66 Suppl 1():S57-64; discussion S65. PubMed ID: 9951803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator and plasminogen activator inhibitor expression by normal and aneurysmal human aortic smooth muscle cells in culture.
    Louwrens HD; Kwaan HC; Pearce WH; Yao JS; Verrusio E
    Eur J Vasc Endovasc Surg; 1995 Oct; 10(3):289-93. PubMed ID: 7552526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smooth muscle cells cultured from human saphenous vein exhibit increased proliferation, invasion, and mitogen-activated protein kinase activation in vitro compared with paired internal mammary artery cells.
    Turner NA; Ho S; Warburton P; O'Regan DJ; Porter KE
    J Vasc Surg; 2007 May; 45(5):1022-8. PubMed ID: 17466797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell lymphokines, interleukin-4 and gamma interferon, modulate the induction of vascular smooth muscle cell tissue plasminogen activator and migration by serum and platelet-derived growth factor.
    Wang W; Chen HJ; Giedd KN; Schwartz A; Cannon PJ; Rabbani LE
    Circ Res; 1995 Dec; 77(6):1095-106. PubMed ID: 7586221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
    Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
    J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization.
    Johnson C; Galis ZS
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):54-60. PubMed ID: 14551157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of endothelial cell overexpression of plasminogen activator inhibitor-1 on smooth muscle cell migration.
    Proia RR; Nelson PR; Mulligan-Kehoe MJ; Wagner RJ; Kehas AJ; Powell RJ
    J Vasc Surg; 2002 Jul; 36(1):164-71. PubMed ID: 12096275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo.
    Forough R; Koyama N; Hasenstab D; Lea H; Clowes M; Nikkari ST; Clowes AW
    Circ Res; 1996 Oct; 79(4):812-20. PubMed ID: 8831505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual cell seeding and the use of zymogen tissue plasminogen activator to improve cell retention on polytetrafluoroethylene grafts.
    Yu H; Wang Y; Eton D; Rowe VL; Terramani TT; Cramer DV; Starnes VA; Weaver FA
    J Vasc Surg; 2001 Aug; 34(2):337-43. PubMed ID: 11496288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pulse pressure on vascular smooth muscle cell migration: the role of urokinase and matrix metalloproteinase.
    Redmond EM; Cahill PA; Hirsch M; Wang YN; Sitzmann JV; Okada SS
    Thromb Haemost; 1999 Feb; 81(2):293-300. PubMed ID: 10064009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effect of retinoic acid and basic FGF on PAI-1 gene expression in vascular smooth muscle cells.
    Watanabe A; Kurabayashi M; Arai M; Sekiguchi K; Nagai R
    Cardiovasc Res; 2001 Jul; 51(1):151-9. PubMed ID: 11399257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue plasminogen activator increases canine endothelial cell proliferation rate through a plasmin-independent, receptor-mediated mechanism.
    Welling TH; Huber TS; Messina LM; Stanley JC
    J Surg Res; 1996 Nov; 66(1):36-42. PubMed ID: 8954829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery.
    Mason DP; Kenagy RD; Hasenstab D; Bowen-Pope DF; Seifert RA; Coats S; Hawkins SM; Clowes AW
    Circ Res; 1999 Dec 3-17; 85(12):1179-85. PubMed ID: 10590245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo.
    Cheng L; Mantile G; Pauly R; Nater C; Felici A; Monticone R; Bilato C; Gluzband YA; Crow MT; Stetler-Stevenson W; Capogrossi MC
    Circulation; 1998 Nov; 98(20):2195-201. PubMed ID: 9815875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.